Beskrivelse
page 235b, XP008136547, ISSN: 0006-4971, ISHIWATARI HIROTOSHI ET AL: "Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes.", GUT SEP 2013, vol.62, no.9, September 2013 (2013-09), pages 1328-1339, XP002716910, ISSN: 1468-3288, YASUSHI SATO ET AL.: 'Kan no Sen'ika o Saguru, Sen'ika no Seigyo to Chiryo no Kanosei, Collagen Seisei Yokusei ni yoru Sen'ika Chiryo no Kanosei(Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against collagen-specific chaperone' KAN-TAN- SUI vol.57, no.2, 28 August 2008, pages 299 - 304, SATO Y. ET AL.: 'Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone' NATURE BIOTECHNOLOGY vol.26, no.4, April 2008, pages 431 - 442, XP055000721, GEORGE J. ET AL.: 'In vivo inhibition of rat stellate cell activation by soluble transforming growth factor type II receptor: A potential new therapy for hepatic fibrosis' PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA vol.96, no.22, 26 October 1999, pages 12719 - 12724, XP003016189, UEKI T. ET AL.: 'Hepatocyte growth factor gene therapy of liver cirrhosis in rats' NATURE MEDICINE vol.5, no.2, February 1999, pages 226 - 230, XP055075609, ANAN A. ET AL.: 'Proteasome Inhibiton Induces Hepatic Stellate Cell Apoptosis' HEPATOLOGY vol.43, no.
2, February 2006, pages 335 - 344, XP055075610, BENEDETTI A. ET AL.: 'Inhibition of the Na+/H+ Exchanger Reduces Rat Hepatic Stellate Cell Activity and Liver Fibrosis: An In Vitro and In Vivo Study' GASTROENTEROLOGY vol.120, no.2, February 2001, pages 545 - 556, XP022380631, GALLI A. ET AL.: 'Antidiabetic Thiazolidinediones Inhibit Collagen Synthesis and Hepatic Stellate Cell Activation In Vivo and In Vitro' GASTROENTEROLOGY vol.122, no.7, 2002, pages 1924 - 1940, XP055075611, PARSONS C.J. ET AL.: 'Antifibrotic Effects of a Tissue Inhibitor of Metalloproteinase-1 Antibody on Established Liver Fibrosis in Rats' HEPATOLOGY vol.40, no.5, November 2004, pages 1106 - 1115, XP008050799, YUJI IIMURO ET AL.: 'Kan Sen'ika to Byotai, 7 MMP-1 Idenshi Donyu ni yoru Kizon Kan Sen'ika no Chiryo' BIO CLINICA vol.16, no.4, 10 April 2001, pages 330 - 334, EP-A1- 2583691
Enclosed is a translation of the patent claims in Norwegian. Please note that as per the Norwegian Patents Acts, section 66i the patent will receive protection in Norway only as far as there is agreement between the translation and the language of the application/patent granted at the EPO. In matters concerning the validity of the patent, language of the application/patent granted at the EPO will be used as the basis for the decision. The patent documents published by the EPO are available through Espacenet (http://worldwide.espacenet.com) or via the search engine on our website here: https://search.patentstyret.no/
Krav
Fullmektig i Norge:
Org.nummer: 979993269
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2010.08.05, JP 2010175920
2010.10.12, JP 2010230020
ANAN A. ET AL.: 'Proteasome Inhibiton Induces Hepatic Stellate Cell Apoptosis' HEPATOLOGY vol. 43, no. 2, February 2006, pages 335 - 344, XP055075610 (B1)
YUJI IIMURO ET AL.: 'Kan Sen'ika to Byotai, 7 MMP-1 Idenshi Donyu ni yoru Kizon Kan Sen'ika no Chiryo' BIO CLINICA vol. 16, no. 4, 10 April 2001, pages 330 - 334 (B1)
EP-A1- 1 842 557 (B1)
EP-A1- 2 583 691 (B1)
EP-A1- 2 609 922 (B1)
GALLI A. ET AL.: 'Antidiabetic Thiazolidinediones Inhibit Collagen Synthesis and Hepatic Stellate Cell Activation In Vivo and In Vitro' GASTROENTEROLOGY vol. 122, no. 7, 2002, pages 1924 - 1940, XP055075611 (B1)
GEORGE J. ET AL.: 'In vivo inhibition of rat stellate cell activation by soluble transforming growth factor type II receptor: A potential new therapy for hepatic fibrosis' PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA vol. 96, no. 22, 26 October 1999, pages 12719 - 12724, XP003016189 (B1)
IIMURO Y. ET AL.: 'Delivery of Matrix Metalloproteinase-1 Attenuates Established Liver Fibrosis in the Rat' GASTROENTEROLOGY vol. 124, no. 2, February 2003, pages 445 - 458, XP055075614 (B1)
ISHIWATARI HIROTOSHI ET AL: "Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes.", GUT SEP 2013, vol. 62, no. 9, September 2013 (2013-09), pages 1328-1339, XP002716910, ISSN: 1468-3288 (B1)
JP-A- 7 300 426 (B1)
PARSONS C.J. ET AL.: 'Antifibrotic Effects of a Tissue Inhibitor of Metalloproteinase-1 Antibody on Established Liver Fibrosis in Rats' HEPATOLOGY vol. 40, no. 5, November 2004, pages 1106 - 1115, XP008050799 (B1)
SATO Y. ET AL.: 'Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone' NATURE BIOTECHNOLOGY vol. 26, no. 4, April 2008, pages 431 - 442, XP055000721 (B1)
UEKI T. ET AL.: 'Hepatocyte growth factor gene therapy of liver cirrhosis in rats' NATURE MEDICINE vol. 5, no. 2, February 1999, pages 226 - 230, XP055075609 (B1)
US-A1- 2009 232 781 (B1)
WATANABE ET AL: "Treatment of idiopathic myelofibrosis employing siRNA for heat shock protein 47 (siRNA/HSP47) encapsulated in liposomes", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 110, no. abstract 4646, 1 January 2007 (2007-01-01), page 235b, XP008136547, ISSN: 0006-4971 (B1)
WO-A1-2006/068232 (B1)
YASUSHI SATO ET AL.: 'Kan no Sen'ika o Saguru, Sen'ika no Seigyo to Chiryo no Kanosei, Collagen Seisei Yokusei ni yoru Sen'ika Chiryo no Kanosei(Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against collagen-specific chaperone' KAN-TAN- SUI vol. 57, no. 2, 28 August 2008, pages 299 - 304 (B1)
BENEDETTI A. ET AL.: 'Inhibition of the Na+/H+ Exchanger Reduces Rat Hepatic Stellate Cell Activity and Liver Fibrosis: An In Vitro and In Vivo Study' GASTROENTEROLOGY vol. 120, no. 2, February 2001, pages 545 - 556, XP022380631 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Batch Varsel om betaling av første årsavgift (3319)
|
Utgående
EP Registreringsbrev (3210)
|
Innkommende, AR222933478
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 14. avg. år (EP) | 2024.08.09 | 5850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 13. avg. år (EP) | 2023.08.09 | 4200 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 12. avg. år (EP) | 2022.08.09 | 3850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2021.08.10 | 3500 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2020.08.11 | 3200 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2019.08.12 | 2850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2018.08.09 | 2550 | CPA GLOBAL LIMITED | Betalt og godkjent |
31718262 expand_more expand_less | 2017.11.22 | 5500 | Bryn Aarflot AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|